Ganoderma lucidum extract reverses hepatocellular carcinoma multidrug resistance via inhibiting the function of P-glycoprotein in vitro and in vivo
Main Article Content
Keywords
Ganoderma lucidum, hepatocellular carcinoma, multidrug resistance, paclitaxel, P-glycoprotein
Abstract
Cancer is a leading cause of death globally. Chemotherapy still plays an indispensable role in the clinical treatment of cancer. However, the emergence of multidrug resistance (MDR) has greatly obstructed the further application of chemotherapy agents. Ganoderma lucidum (G. lucidum) is a traditional Chinese medicine as well as an edible mushroom. In this study, we first explored the effect of six extract samples derived from G. lucidum on the cell viability of adriamycin-resistant human hepatocellular carcinoma multidrug-resistant cell subline (HepG-2/ADM). All these samples showed no obvious toxicity to cells; however, only G. lucidum ethanol extract could reverse resistance to doxorubicin and paclitaxel. Then the P-glycoprotein (P-gp) function in hepatocellular carcinoma G2 (HepG-2) and HepG-2/ADM cells was determined after incubated with these samples, and we found that G. lucidum ethanol extract could inhibit P-gp function in vitro. Furthermore, G. lucidum ethanol extract could reverse resistance to paclitaxel in HepG-2/ADM tumor-bearing mice in vivo, while the protein expression level of P-gp was unchanged. Taken together, these results indicated the potential role of G. lucidum ethanol extract in reversing MDR in the clinical treatment of hepatocellular carcinoma.
References
Ammar, M., Louati, N., Frikha, I., Medhaffar, M., Ghozzi, H., Elloumi, M., Menif, H., Zeghal, K. and Ben Mahmoud, L., 2020. Overexpression of P-glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients. J Clin Lab Anal. 34: e23374. 10.1002/jcla.23374
Bray, F., Laversanne, M., Weiderpass, E. and Soerjomataram, I., 2021. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127: 3029–3030. 10.1002/cncr.33587
Cai, Z., Wong, C.K., Dong, J., Jiao, D., Chu, M., Leung, P.C., Lau, C.B.S., Lau, C.P., Tam, L.S. and Lam, C.W.K., 2016. Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus. Chin Med. 11: 23. 10.1186/s13020-016-0093-x
Chan, S.W., Tomlinson, B., Chan, P. and Lam, C.W.K., 2021. The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk. Pharm Biol. 59: 1161–1171. 10.1080/13880209.2021.1969413
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L. and Li, J., 2016. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 370: 153–164. 10.1016/j.canlet.2015.10.010
Cor, D., Knez, Z. and Knez Hrncic, M., 2018. Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides: a review. Molecules. 23: 649. 10.3390/molecules23030649
Ding, Y., Fan, J., Fan, Z. and Zhang, K., 2021. Gamma-tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the gamma-tocotrienol-NF--kappaB-P-gp axis. J Steroid Biochem Mol Biol. 209: 105835. 10.1016/j.jsbmb.2021.105835
Gottesman, M.M., Fojo, T. and Bates, S.E., 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Rev Cancer. 2: 48–58. 10.1038/nrc706
Hu, T., To, K.K., Wang, L., Zhang, L., Lu, L., Shen, J., Chan, R.L., Li, M., Yeung, J.H. and Cho, C.H., 2014. Reversal of P-glycoprotein (P-gp)-mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine. 21: 1264–1272. 10.1016/j.phymed.2014.06.013
Jin, X., Ruiz Beguerie, J., Sze, D.M. and Chan, G.C., 2016. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 4: CD007731. 10.1002/14651858.CD007731.pub3
Komori, Y., Arisawa, S., Takai, M., Yokoyama, K., Honda, M., Hayashi, K., Ishigami, M., Katano, Y., Goto, H., Ueyama, J., Ishikawa, T. and Wakusawa, S., 2014. Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells. Eur J Pharmacol. 724: 161–167. 10.1016/j.ejphar.2013.12.023
Kumar, A. and Jaitak, V., 2019. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem. 176: 268–291. 10.1016/j.ejmech.2019.05.027
Li, J., Gu, F., Cai, C., Hu, M., Fan, L., Hao, J. and Yu, G., 2020. Purification, structural characterization, and immunomodulatory activity of the polysaccharides from Ganoderma lucidum. Int J Biol Macromol. 143: 806–813. 10.1016/j.ijbiomac.2019.09.141
Ma, H.T., Hsieh, J.F. and Chen, S.T., 2015. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 114: 109–113.
Robey, R.W., Pluchino, K.M., Hall, M.D., Fojo, A.T., Bates, S.E. and Gottesman, M.M., 2018. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nature Rev Cancer. 18: 452–464. 10.1038/s41568-018-0005-8
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F., 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 71: 209–249. 10.3322/caac.21660
Szakacs, G., Paterson, J.K., Ludwig, J.A., Booth-Genthe, C. and Gottesman, M.M., 2006. Targeting multidrug resistance in cancer. Nature Rev. Drug Discov. 5: 219–234. 10.1038/nrd1984
Zeino, M., Paulsen, M.S., Zehl, M., Urban, E., Kopp, B. and Efferth, T., 2015. Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids. Biochem Pharmacol. 93: 11–24. 10.1016/j.bcp.2014.10.009
Zhang, Y., Cai, H., Tao, Z., Yuan, C., Jiang, Z., Liu, J., Kurihara, H. and Xu, W., 2021. Ganoderma lucidum spore oil (GLSO), a novel antioxidant, extends the average life span in Drosophila melanogaster. Food Sci Hum Wellness. 10: 38–44. 10.1016/j.fshw.2020.05.011
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Agreement with Authors
Before publication, after the acceptance of the manuscript, Authors have to sign a Publication Agreement with "Italian Journal of Food Science", granting and assigning to "Italian Journal of Food Science" the perpetual right to distribute the work free of charge by any means and in any parts of the world, including the communication to the public through the journal website.
License for Published Contents
http://creativecommons.org/licenses/by-nc-nd/4.0/